Ftse Mib
34.314,73
-0,18%
DAX
18.496,07
-0,56%
S&P 500
5.641,68
0,19%
NASDAQ
18.440,17
-0,18%
Bitcoin
63.793,86
-1,63%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AbCellera Biologics Inc (ABCL) AbCellera Biologics Inc (ABCL) Notizie

ABCL

AbCellera Biologics (ABCL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL
DataOraFonteTitoloSimboloCompagnia
01/04/202116:37Dow Jones NewsAbCellera Biologics Up; Expands Agreement With GileadNASDAQ:ABCLAbCellera Biologics Inc
01/04/202115:00Business WireAbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery CollaborationNASDAQ:ABCLAbCellera Biologics Inc
01/04/202113:49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABCLAbCellera Biologics Inc
31/03/202100:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ABCLAbCellera Biologics Inc
29/03/202122:05Business WireAbCellera Reports Full Year 2020 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
10/03/202118:32Dow Jones NewsAbCellera Posts Positive Results For Advanced Covid-19 Treatment TrialNASDAQ:ABCLAbCellera Biologics Inc
10/03/202117:21Business WireAbCellera-Discovered Bamlanivimab Together with Etesevimab Reduced Hospitalizations & Prevented Death in Phase 3 Trial for Ea...NASDAQ:ABCLAbCellera Biologics Inc
05/03/202123:00Dow Jones NewsAbCellera's Covid-19 Treatment Gets Recommendation From European RegulatorsNASDAQ:ABCLAbCellera Biologics Inc
05/03/202121:30Business WireEMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 PatientsNASDAQ:ABCLAbCellera Biologics Inc
17/02/202122:05Business WireAbCellera to Present at the SVB Leerink Global Healthcare ConferenceNASDAQ:ABCLAbCellera Biologics Inc
16/02/202122:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ABCLAbCellera Biologics Inc
16/02/202112:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ABCLAbCellera Biologics Inc
11/02/202122:05Business WireAbCellera Appoints Ester Falconer, Ph.D., as Chief Technology OfficerNASDAQ:ABCLAbCellera Biologics Inc
10/02/202102:26Business WireAbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Receives FDA Emergency Use Authorization for COVID-19NASDAQ:ABCLAbCellera Biologics Inc
03/02/202122:05Business WireAbCellera Announces Date of Fourth Quarter 2020 Financial Results Conference CallNASDAQ:ABCLAbCellera Biologics Inc
27/01/202113:22Business WireAbCellera-Discovered Antibody, Bamlanivimab, to be Developed with VIR-7831 for the Treatment of COVID-19NASDAQ:ABCLAbCellera Biologics Inc
26/01/202113:09Business WireAbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Reduced Risk of COVID-19 Hospitalizations & Death b...NASDAQ:ABCLAbCellera Biologics Inc
21/01/202114:27Business WireAbCellera-Discovered Antibody Prevented COVID-19 in Nursing Homes and Reduced Risks by up to 80% for ResidentsNASDAQ:ABCLAbCellera Biologics Inc
19/01/202122:41Business WireAbCellera Granted U.S. Patent Covering its Trianni Mouse® TechnologyNASDAQ:ABCLAbCellera Biologics Inc
11/01/202116:18Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:ABCLAbCellera Biologics Inc
05/01/202115:30PR Newswire (Canada)2020 Canadian IPO mixed results - number (77) down, amount ($5.55B) up driven by PE-backed IPOsNASDAQ:ABCLAbCellera Biologics Inc
21/12/202015:00Business WireAbCellera-Discovered Neutralizing Antibody for COVID-19 Enters New Pragmatic Study in New MexicoNASDAQ:ABCLAbCellera Biologics Inc
16/12/202003:03Business WireAbCellera Announces Closing of Initial Public Offering & Exercise in Full of the Underwriters’ Option to Purchase Additiona...NASDAQ:ABCLAbCellera Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL

La tua Cronologia

LSE
ESG
Eservglobal
COIN
FETUSD
Fetch
COIN
MINAUSD
Mina
LSE
SKG
Smurfit Kappa
LSE
TIGB
Ivz Ust 0-1 Gbh
LSE
PRAC
Ivz Prf Shr Acc
LSE
JET2
Jet2
NASDAQ
BKRS
Bakers Footwear
NYSE
PBA
Pembina Pipeline
NASDAQ
LCAHU
Landcadia Holdings IV
BOV
TRNT11
Fdo Invest Imobiliario T...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network